Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC

Few therapeutic options are available for T790M-negative non-small cell lung cancer (NSCLC) after failure of primary epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy. This report presents the case of a 71-year-old Asian female never smoker with EGFR mutated T7...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Med Case Rep
Hlavní autoři: Carter, Corey A., Oronsky, Bryan, Caroen, Scott, Scicinski, Jan, Cabrales, Pedro, Degesys, Aiste, Brzezniak, Christina
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2016
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4913156/
https://ncbi.nlm.nih.gov/pubmed/27330954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2016.04.007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky